Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Empty Capsules Market worth $4.19 billion by 2030 with 5.6% CAGR | MarketsandMarkets™

This image opens in the lightbox

News provided by

MarketsandMarkets

22 Aug, 2025, 14:45 GMT

Share this article

Share toX

Share this article

Share toX

DELRAY BEACH, Fla., Aug. 22, 2025 /PRNewswire/ -- The global Empty Capsules Market, valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$4.19 billion by the end of the period. The empty capsules market is propelled by increasing demand for nutraceuticals and personalized supplements, expansion in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options, combined with sustainability-driven regulations, is further accelerating adoption. Future growth is anticipated from localized production in emerging markets and the creation of biodegradable capsules.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190

Browse in-depth TOC on "Empty Capsules Market"
356 - Tables
48 - Figures
459 - Pages

By functionality, the empty capsules market is categorized into immediate-release capsules, sustained-release capsules, delayed-release capsules, and modified-release capsules. The immediate-release capsules segment is the largest in the empty capsules market. These capsules are typically used for medications and supplements where a rapid onset of action is necessary. They are the most commonly used type of capsule, favored for their simple formulation and relatively low production cost. Immediate-release capsules are employed in treating acute conditions such as pain relief, antibiotics, and other fast-acting drugs.

By application, the empty capsules market is categorized based on therapeutic applications, including antibiotic and antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold treatments, and other therapeutic uses. Among these, the dietary supplements segment is the fastest growing, driven by the increasing demand for natural supplements, probiotics, and vegan alternatives. This growth is fueled by a shift toward preventive healthcare and a rising interest in personalized nutrition. Additionally, the development of plant-based and clean-label products contributes to this segment's expansion as consumers become more health-conscious and choose supplements that match their dietary preferences. The global aging population and the rising prevalence of lifestyle diseases also boost the reliance on dietary supplements as part of proactive health management.

By geography, the empty capsules market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America held the largest share of the global empty capsules market, driven by its well-established pharmaceutical and nutraceutical industries, high healthcare expenditure, and increasing demand for dietary supplements. Furthermore, the rising preference for vegetarian and clean-label capsules among health-conscious consumers has further fueled demand. Regulatory support and a high volume of clinical trials also help maintain the region's leading position in the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=218018190

Key players in the empty capsules market include Lonza (Switzerland), ACG (India), Qualicaps (US), Suheung (South Korea), and Shanxi Guangsheng Capsule Limited (China), among others. Some of the SMEs/start-ups operating in this market includes Saviour Caps (India), Shanxi JC Biological Technology Co. (China), Shaoxing Kangke Capsule Co., Ltd. (China), ZHEJIANG HUILI CAPSULES CO., LTD. (China), and Lefancaps (Canada), among others.

Lonza (Switzerland):

Lonza (Switzerland), through its Capsules & Health Ingredients (CHI) segment (formerly Capsugel), offers a broad portfolio of gelatin and non-gelatin capsules, including well-known brands like Vcaps, Vcaps Plus, DRcaps, and Enprotect, serving both pharmaceutical and nutraceutical industries. With a production capacity of approximately 260 billion capsules and over 12 manufacturing sites, Lonza operates globally, supporting more than 5,000 customers. In 2024, Lonza's CHI segment generated USD 1.27 billion in revenue, despite weakening demand in consumer health. Lonza highlighted capsule innovation by expanding its targeted release technologies and plant-based portfolio in line with clean-label trends. The company launched Capsugel Enprotect in 2022, the first coating-free capsule for enteric drug delivery, targeting small molecules, peptides, proteins, and RNA-based therapeutics. Lonza maintained its market position through a broad portfolio, trusted quality, global presence, strong customer relationships, technological leadership, and operational efficiency. In December 2024, Lonza announced the separation of its CHI business and plans to operate solely as a CDMO. The separation is expected to take effect in Q2 2025.

ACG (India)

ACG (India) is the second-largest global player and the leading capsule manufacturer from India, with a strong international presence in gelatin and HPMC capsules manufacturing. ACG Capsules (ACPL) is projected to generate USD 400 million in 2024. The company is focused on expanding globally, especially through new facilities in Thailand and upgrades to its Croatia plant. ACG also offers customized capsule solutions, including halal and kosher-certified gelatin, catering to Middle Eastern and Southeast Asian markets. Its strengths include cost competitiveness, regulatory flexibility, and a vertically integrated supply chain, positioning ACG as a dependable partner for both pharma and nutraceutical sectors and CDMOs.

For more information, Inquire Now!

Related Reports:

Pharmaceutical Packaging Equipment Market

Active Pharmaceutical Ingredient Market

Pharmaceutical Contract Manufacturing Market

Drug Discovery Services Market

Pharmaceutical Excipients Market 

Get access to the latest updates on Empty Capsules Companies and Empty Capsules Market Size

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Modal title

Also from this source

Smart City Platforms Market worth $39.52 billion by 2030| MarketsandMarkets™

Smart City Platforms Market worth $39.52 billion by 2030| MarketsandMarkets™

According to MarketsandMarkets™, the global Smart City Platforms Market will grow from USD 24.51 billion in 2025 to USD 39.52 billion by 2030 at a...

Medical Device Contract Manufacturing Market worth $140.84 billion by 2030 with 10.9% CAGR | MarketsandMarkets™

Medical Device Contract Manufacturing Market worth $140.84 billion by 2030 with 10.9% CAGR | MarketsandMarkets™

The global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.